Takeda’s Actos On U.S. FDA List For Closer Side-Effects Look
This article was originally published in PharmAsia News
Executive Summary
A Takeda Pharmaceutical drug has been placed on a U.S. FDA list of products that pose potential health risks, making them subject to a closer look